The Latest Breaking News from antibiotic

Zosurabalpin has defeated strains of pneumonia and sepsis in mice, raising hopes for human trials

Over half of the almost 10,000 hospital patients surveyed recently were given antibiotics to prevent infection, rather than to treat it, amidst growing concerns about the rise in resistance to antibiotics.

The Rosalind Franklin Laboratory – which has received more than £1 billion of public funding – is currently on sale on Rightmove.

Kerala Health Minister announces programme to make all FHCs antibiotic-smart & discourage sale of antibiotics without prescription.

An algorithm reduced rates of antibiotics use in kids treated at Tanzanian primary care facilities without compromising their chances of getting better.

Urinary tract infections have been a cause of chronic distress for generations of menopausal women. Campaigning journalist Kate Muir argues the problem could be halved if an alternative treatment to antibiotics is better understood. So why isn’t more being done?

Antimicrobial resistance (AMR) is one of the World Health Organization’s most urgent health challenges for the next decade. While AMR is a global threat, a tale of two worlds emerges, highlighting the heightened vulnerability of low- and middle-income countries (LMICs).

The biotech industry is well-positioned for solid growth due to rising demand for quality treatments and therapies, a rapidly aging population, adoption of technologies like AI and government initiatives. To leverage these trends, consider investing in quality biotech stocks Innoviva (INVA), Puma Biotechnology (PBYI), and Shionogi (SGIOY). Keep reading….

A new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.

Other lives: Academic pharmacist and pharmaceutical microbiologist who specialised in understanding how bacteria respond to antibiotics

Antimicrobial resistance is one of the biggest global threats to health, food security and development. This month, The Conversation’s experts explore how we got here and the potential solutions.